Latest Advances in Assisted Reproductive Technologies (ART)/In Vitro Fertilization (IVF)
A Special Issue of Journal of Clinical Medicine (ISSN 2077-0383) belonging to the section "Obstetrics & Gynecology".
Deadline for manuscript submissions: 20 October 2026 | Viewed by 1323
Editor
Special Issue Information
Dear Colleagues,
Assisted reproductive technology (ART) and in vitro fertilization (IVF) continue to evolve rapidly, driven by advances in embryology, ovarian stimulation, cryopreservation, and reproductive genetics. These innovations in ART/IVF are essential processes to improve embryo competence, optimize embryo selection, and personalize ovarian stimulation protocols, thereby increasing success rates while minimizing treatment burden and risks. rates while reducing risks. Emerging technologies, particularly artificial intelligence (AI) and advanced genetic testing, can offer new opportunities to enhance embryo assessment and improve accuracy, support evidence-based clinical decision-making, and enable personalized reproductive care.
The IVF goals are to achieve a higher success rate per cycle, fewer treatment attempts, and improved safety. In parallel, improvements in cryopreservation and individualized stimulation strategies have expanded fertility preservation options, including for patients undergoing gonadotoxic treatments and individuals who choose to electively delay parenthood, to get care tailored to each one.
However, key challenges remain, particularly regarding the enigma of endometrial receptivity. And the mechanisms underlying embryo implantation.
Further research integrating molecular, immunological, and clinical data—potentially supported by AI—may help refine treatment strategies and improve implantation rates, perhaps by using AI to help identify the optimal window of implantation.
Research in ART/IVF is practically timely due to major changes given a global trend of delaying parenthood, rising infertility prevalence, and increasing demand for fertility treatments and care. High-quality clinical and translational studies are essential to advance knowledge for both scientific and clinical practice and improve patient outcomes.
This Special Issue aims to present and disseminate the latest advances related to IVF and ART, with particular focus on treatment individualization, innovations in embryology and embryo selection, and integration of emerging technologies into clinical practice.
Topics of interest include, but are not limited to, ovarian reserve assessment and management of poor ovarian response (POR), the clinical application of biomarkers such as anti-Mullerian hormone (AMH) and antral follicle count (AFC), advances in embryology technologies, and the use of AI and other novel approaches to optimize embryo selection and treatment outcomes.
Dr. Ravit Nahum
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- IVF
- POR
- embryo selection
- endometrium
- technology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
